DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants
Christopher S. Semancik, Naisi Zhao, Devin C. Koestler, Eric Boerwinkle, Jan Bressler, Rachel J. Buchsbaum, Karl T. Kelsey, Elizabeth A. Platz, Dominique S. Michaud
doi: https://doi.org/10.1101/2024.05.09.24307118
Christopher S. Semancik
1Department of Public Health & Community Medicine, Tufts University School of Medicine, Tufts University, Boston, MA, USA
Naisi Zhao
1Department of Public Health & Community Medicine, Tufts University School of Medicine, Tufts University, Boston, MA, USA
Devin C. Koestler
2The University of Kansas Cancer Center, Kansas City, KS, USA
3Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA
Eric Boerwinkle
4Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA
5Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
Jan Bressler
4Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA
Rachel J. Buchsbaum
6Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA
Karl T. Kelsey
7Department of Epidemiology, Brown University, Providence, RI, USA
8Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA
Elizabeth A. Platz
9Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
10The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
Dominique S. Michaud
1Department of Public Health & Community Medicine, Tufts University School of Medicine, Tufts University, Boston, MA, USA
Data Availability
Due to its proprietary nature, supporting data from the Atherosclerosis Risk in Communities cohort cannot be made openly available. Further information about the data and conditions for access are available at the Atherosclerosis Risk in Communities website at https://aric.cscc.unc.edu/aric9/.
Posted May 09, 2024.
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants
Christopher S. Semancik, Naisi Zhao, Devin C. Koestler, Eric Boerwinkle, Jan Bressler, Rachel J. Buchsbaum, Karl T. Kelsey, Elizabeth A. Platz, Dominique S. Michaud
medRxiv 2024.05.09.24307118; doi: https://doi.org/10.1101/2024.05.09.24307118
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants
Christopher S. Semancik, Naisi Zhao, Devin C. Koestler, Eric Boerwinkle, Jan Bressler, Rachel J. Buchsbaum, Karl T. Kelsey, Elizabeth A. Platz, Dominique S. Michaud
medRxiv 2024.05.09.24307118; doi: https://doi.org/10.1101/2024.05.09.24307118
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)